研究概述:认知功能障碍的危险因素及发病机制
发表论文:
1.Lv R, Liu X, Zhang Y, Dong N, Wang X, He Y, Yue H*, Yin Q*. Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. Signal Transduct Target Ther. 2023 May 25;8(1):218.
2.Jiang Z, Wang X, Zhang H, Yin J, Zhao P, Yin Q*, Wang Z*. Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites. MedComm (2020). 2023 May 16;4(3):e268.
3.Zhao Z, Hou X, Li S, Xu W, Yin Q*. Progress, Challenges, and Opportunities of Geriatric Medicine in China. Aging Dis. 2022 Oct 1;13(5):1314-1316.
4.Yin Q, Liu X, Huang C, Bi W, Zhou R, Lv R. Effect of COVID-19 on Geriatric Medical Services in China. Aging Dis. 2022 Feb 1;13(1):4-7.
5.Ma S, Bi W, Liu X, Li S, Qiu Y, Huang C, Lv R, Yin Q*. Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction. Front Endocrinol (Lausanne). 2022 Jun 1;13:891039.
6.Tan Y, Zheng Y, Xu D, Sun Z, Yang H, Yin Q*. Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease. Cell Biosci. 2021 Apr 27;11(1):78.
7.Lv R, Yin Q*. Prevention and Management of COVID-19 in Patients with Dementia Living at Home: Experience from China. Aging Dis. 2021 Jun 1;12(3):684-687.
8.Yin Q, Chen J, Ma S, Dong C, Zhang Y, Hou X, Li S, Liu B. Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro. J Inflamm Res. 2020 Sep 15;13:533-542.
9.Yin Q, Ji X, Lv R, Pei JJ, Du Y, Shen C, Hou X. Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer's Disease. Clin Interv Aging. 2020 Feb 13;15:195-205.
10.Ma S, Li S, Lv R, Hou X, Nie S, Yin Q*. Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin-3 level. J Diabetes Investig. 2020 Sep;11(5):1295-1302.
主持课题:
国家自然科学基金,面上项目,Chemerin/CMKLR1通过G蛋白成员G15调控小胶质细胞炎症促进糖尿病认知功能障碍的作用及机制研究,2025-01至2028-12,48万;